Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fujingshu Tablets for Chronic Pelvic Inflammatory Disease Sequelae
CTR20150286Phase 3Active
- Sponsor
- Xi'an Tianrui Pharmaceutical Development Co., Ltd.
- Start
- May 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Fujingshu Tablets in Pelviabdominal infection, sponsored by Xi'an Tianrui Pharmaceutical Development Co., Ltd.. Started May 2015; status: active.
02
Drugs
Fujingshu Tablets
03
Conditions
Pelviabdominal infection
Beyond the preview
Go deeper on CTR20150286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150286.